Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae
- PMID: 34050325
- DOI: 10.1038/s41429-021-00427-0
Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae
Abstract
Trans-translation is a unique bacterial ribosome rescue system that plays important roles in the tolerance to environmental stresses. It is composed of an ssrA-encoded tmRNA and a protein SmpB. In this study, we examined the role of trans-translation in antibiotic tolerance in Klebsiella pneumoniae and explored whether the inhibition of this mechanism could enhance the bactericidal activities of antibiotics. We found that deletion of the ssrA gene reduced the survival of K. pneumoniae after treatment with kanamycin, tobramycin, azithromycin, and ciprofloxacin, indicating an important role of the trans-translation in bacterial antibiotic tolerance. By using a modified ssrA gene with a 6×His tag we demonstrated that tobramycin suppressed the azithromycin and ciprofloxacin-elicited activation of trans-translation. The results were further confirmed with a trans-translation reporter system that is composed of a normal mCherry gene and a gfp gene without the stop codon. Compared to each individual antibiotic, combination of tobramycin with azithromycin or ciprofloxacin synergistically enhanced the killing activities against planktonic K. pneumoniae cells and improved bacterial clearance in a murine cutaneous abscess infection model. In addition, the combination of tobramycin and ciprofloxacin increased the bactericidal activities against biofilm-associated cells. Overall, our results suggest that the combination of tobramycin with azithromycin or ciprofloxacin is a promising strategy in combating K. pneumoniae infections.
© 2021. The Author(s), under exclusive licence to the Japan Antibiotics Research Association.
Similar articles
-
Enhancing bactericidal activities of ciprofloxacin by targeting the trans-translation system that is involved in stress responses in Klebsiella pneumoniae.Arch Microbiol. 2024 Mar 13;206(4):154. doi: 10.1007/s00203-024-03872-1. Arch Microbiol. 2024. PMID: 38478112
-
Synergistic antibiotic combinations for colistin-resistant Klebsiella pneumoniae.Acta Microbiol Immunol Hung. 2013 Jun;60(2):201-9. doi: 10.1556/AMicr.60.2013.2.10. Acta Microbiol Immunol Hung. 2013. PMID: 23827751
-
Investigation of the effects of various antibiotics against Klebsiella pneumoniae biofilms on in vitro catheter model.J Chemother. 2018 Apr;30(2):82-88. doi: 10.1080/1120009X.2017.1390633. Epub 2017 Oct 24. J Chemother. 2018. PMID: 29063819
-
The Characteristic of Virulence, Biofilm and Antibiotic Resistance of Klebsiella pneumoniae.Int J Environ Res Public Health. 2020 Aug 28;17(17):6278. doi: 10.3390/ijerph17176278. Int J Environ Res Public Health. 2020. PMID: 32872324 Free PMC article. Review.
-
Promising strategies for future treatment of Klebsiella pneumoniae biofilms.Future Microbiol. 2020 Jan;15:63-79. doi: 10.2217/fmb-2019-0180. Epub 2020 Feb 12. Future Microbiol. 2020. PMID: 32048525 Review.
Cited by
-
The resistance mechanisms of bacteria against ciprofloxacin and new approaches for enhancing the efficacy of this antibiotic.Front Public Health. 2022 Dec 21;10:1025633. doi: 10.3389/fpubh.2022.1025633. eCollection 2022. Front Public Health. 2022. PMID: 36620240 Free PMC article. Review.
-
Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii.Pharmaceutics. 2022 Jan 5;14(1):130. doi: 10.3390/pharmaceutics14010130. Pharmaceutics. 2022. PMID: 35057026 Free PMC article.
References
-
- Jensen TS, Opstrup KV, Christiansen G, Rasmussen PV, Thomsen ME, Justesen DL, et al. Complement mediated Klebsiella pneumoniae capsule changes. Microbes Infect. 2020;22:19–30. - DOI
-
- Kobayashi SD, DeLeo FR. Re-evaluating the potential of immunoprophylaxis and/or immunotherapy for infections caused by multidrug resistant Klebsiella pneumoniae. Future Microbiol. 2018;13:1343–6. - DOI
-
- Bassetti M, Righi E, Carnelutti A, Graziano E, Russo A. Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control. Expert Rev Anti Infect Ther. 2018;16:749–61. - DOI
-
- Himeno H, Nameki N, Kurita D, Muto A, Abo T. Ribosome rescue systems in bacteria. Biochimie. 2015;114:102–12. - DOI
-
- Huter P, Müller C, Arenz S, Beckert B, Wilson DN. Structural basis for ribosome rescue in bacteria. Trends biochemical Sci. 2017;42:669–80. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
